Jessica Robinson?Papp|Kathryn Elliott|David M. Simpson|Susan Morgello
Problematic Prescription Opioid Use in an HIV-Infected Cohort
Icahn School of Medicine at Mount Sinai|Icahn School of Medicine at Mount Sinai|Icahn School of Medicine at Mount Sinai|Icahn School of Medicine at Mount Sinai
providers treating chronic pain must attempt relieve suffering minimizing problematic prescription opioid use including addiction diversion previously described risk factors problematic use include history substance use younger age male sex psychiatric comorbidity lower education levelwe examined risk factors hivinfected individuals using crosssectional longitudinal data manhattan hiv brain bank problematic use defined illicit substance use documented urine toxicology structured psychiatric interview receiving prescription opioidsamong 173 participants prescribed opioids 62 problematic use majority discovered urine toxicology problematic use associated past substance use current psychiatric disorder poorer adherence antiretrovirals however participants without problematic use baseline followed longitudinally factors predictive furthermore cumulative incidence problematic use behaviors greater similar group participants prescribed opioidsproblematic prescription opioid use common among hivinfected individuals associated history substance use current psychiatric disorder poor adherence antiretrovirals however factors predict future problematic use currently using illicit substances prescription opioid seem predispose patients toward future substance use disorder rather attempting assess risk problematic prescription opioid use hivinfected individuals recommend baseline followup urine toxicology